Real-world MS relapse rate is low for dimethyl fumarate

NATIONAL HARBOR, MD. – A real-world comparison of relapse rates in multiple sclerosis (MS) patients for five disease-modifying therapies (DMTs) found the largest decrease for delayed-release dimethyl...
Source: Clinical Neurology News - Category: Neurology Source Type: news